GPWA
TMO icon

Gaddis Premier Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Gaddis Premier Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
2,173
+8
+0.4% +$3.84K 0.66% 26
2026
Q1 		$1.06M Hold
2,165
– – 0.78% 22
2025
Q4 		$1.25M Buy
+2,165
New +$1.22M 0.95% 20

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Gaddis Premier Wealth Advisors's TMO Position: Q2 2026 in Review

Gaddis Premier Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.37% in Q2 2026, buying an estimated $3.84K and bringing the position to 2,173 shares worth $1.09M. The position accounts for 0.66% of the portfolio, ranked #26.

Gaddis Premier Wealth Advisors first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Gaddis Premier Wealth Advisors held 2,173 shares of Thermo Fisher Scientific worth $1.09M as of Q2 2026.
  • Gaddis Premier Wealth Advisors bought 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.66% of Gaddis Premier Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • Gaddis Premier Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Gaddis Premier Wealth Advisors's Thermo Fisher Scientific position peaked at $1.25M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gaddis Premier Wealth Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.